Informing patients about drug side effects.
Two hundred forty-nine newly diagnosed hypertensive patients prescribed thiazide medication were recruited for study. Two-thirds were given a leaflet or patient package insert (PPI) that described the drug and its possible side effects, and one-third were not. At a revisit about 1 month later, patients were asked whether they had experienced any of 17 different "health problems." For each problem that they experienced, they were asked whether they thought the problem was related to the medicine they were taking. Ten of the health problems were taken verbatim from the PPI's list of possible drug side effects. Patients who received the PPI reported experiencing about the same number of side effects as the non-PPI subjects. However, those who received the PPI were more likely to attribute experienced reactions to the drug. This was true for both reactions specifically listed in the PPI and for similar reactions not listed. Results support the notion of an "attribution-labeling" process rather than a "suggestion" effect.
D001581:Benzothiadiazines; D032882:Comprehension; D035061:Control Groups; D004232:Diuretics; D004348:Drug Labeling; D004358:Drug Therapy / Q000523:psychology; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D018570:Risk Assessment; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D013404:Suggestion; D014342:Truth Disclosure
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors